• Dr. Angélique VIENOT

    Gastroenterologist

    University Hospital of Besançon

    angelique.vienot@gmail.com



Main publications

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Angélique VIENOT, Mme. Aurélia MEURISSE
Journal name : JNCI J Natl Cancer Inst

Latest publications

sample

AbstractFluoropyrimidine (FP) plus platinum chemotherapy has been recently established as a second-line (L2) preferred...

Posted by : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Dr. Angélique VIENOT
Journal name : Int J Cancer

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Angélique VIENOT, Mme. Aurélia MEURISSE
Journal name : JNCI J Natl Cancer Inst

sample

AbstractBackground: FOLFIRINOX regimen is the first-line reference chemotherapy (L1) in advanced pancreatic ductal...

Posted by : Dr. Angélique VIENOT, Dr. Dewi VERNEREY
Journal name : World J Gastrointest Oncol

sample

AbstractBackground: Surgical resection with adjuvant chemotherapy is the only treatment that can provide long term...

Posted by : Dr. Dewi VERNEREY, , Dr. Angélique VIENOT
Journal name : Front Oncol

sample

AbstractDocetaxel, cisplatin and 5-fluorouracil (DCF) chemotherapy regimen is highly effective in advanced anal squamous...

Posted by : Dr. Dewi VERNEREY, Dr. Angélique VIENOT, Mme. Aurélia MEURISSE
Journal name : Int J Mol Sci

sample

Background:The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...

Posted by : Dr. Angélique VIENOT, Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : British Journal of Cancer

Latest tools

Currently, the management of advanced pancreatic cancer patients is complex in second-line chemotherapy according to the...

Posted by : Dr. Angélique VIENOT, Dr. Dewi VERNEREY

2015-2023 © Copyright - UMQVC.org

Website by Pearlweb